Siemens Healthineers (OTCMKTS:SMMNY) Downgraded by JPMorgan Chase & Co. to “Underweight”

JPMorgan Chase & Co. lowered shares of Siemens Healthineers (OTCMKTS:SMMNY) from a neutral rating to an underweight rating in a research note released on Thursday, September 19th, The Fly reports.

SMMNY traded up $0.26 on Thursday, hitting $19.18. 31,137 shares of the company were exchanged, compared to its average volume of 96,584. Siemens Healthineers has a 12 month low of $18.89 and a 12 month high of $22.43.

About Siemens Healthineers

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services worldwide. The company's Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. Its Advanced Therapies segment produces integrated products, solutions, and services for therapy departments of healthcare providers.

Featured Article: Why Net Income is Important to Investors

The Fly

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.